Off-label antiobesity treatment in patients without diabetes with GLP-1 agonists in clinical practice
N Sauer, F Reining, CS Zur Wiesch… - Hormone and …, 2015 - thieme-connect.com
The aim of the work was to investigate whether continuation of treatment, side effects, and
effect on weight loss of GLP-1 agonists in obese patients without diabetes are equally …
effect on weight loss of GLP-1 agonists in obese patients without diabetes are equally …
Off-label antiobesity treatment in patients without diabetes with GLP-1 agonists in clinical practice.
N Sauer, F Reining, C Schulze Zur Wiesch… - Hormone and …, 2014 - europepmc.org
The aim of the work was to investigate whether continuation of treatment, side effects, and
effect on weight loss of GLP-1 agonists in obese patients without diabetes are equally …
effect on weight loss of GLP-1 agonists in obese patients without diabetes are equally …
Off-label antiobesity treatment in patients without diabetes with GLP-1 agonists in clinical practice.
N Sauer, F Reining, C Schulze zur Wiesch, T Burkhardt… - 2015 - cabidigitallibrary.org
The aim of the work was to investigate whether continuation of treatment, side effects, and
effect on weight loss of GLP-1 agonists in obese patients without diabetes are equally …
effect on weight loss of GLP-1 agonists in obese patients without diabetes are equally …
Off-label antiobesity treatment in patients without diabetes with GLP-1 agonists in clinical practice
N Sauer, F Reining, CS Zur Wiesch… - Hormone and …, 2015 - pubmed.ncbi.nlm.nih.gov
The aim of the work was to investigate whether continuation of treatment, side effects, and
effect on weight loss of GLP-1 agonists in obese patients without diabetes are equally …
effect on weight loss of GLP-1 agonists in obese patients without diabetes are equally …